Lamba N, Wen PY, Aizer AA (2021) Epidemiology of brain metastases and leptomeningeal disease. Neuro Oncol 23:1447–1456. https://doi.org/10.1093/neuonc/noab101

Article  PubMed  PubMed Central  Google Scholar 

Aizer AA, Lamba N, Ahluwalia MS, Aldape K, Boire A, Brastianos PK, Brown PD, Camidge DR, Chiang VL, Davies MA, Hu LS, Huang RY, Kaufmann T, Kumthekar P, Lam K, Lee EQ, Lin NU, Mehta M, Parsons M, Reardon DA, Sheehan J, Soffietti R, Tawbi H, Weller M, Wen PY (2022) Brain metastases: a Society for Neuro-Oncology (SNO) consensus review on current management and future directions. Neuro Oncol 24:1613–1646. https://doi.org/10.1093/neuonc/noac118

Article  CAS  PubMed  PubMed Central  Google Scholar 

Gondi V, Bauman G, Bradfield L, Burri SH, Cabrera AR, Cunningham DA, Eaton BR, Hattangadi-Gluth JA, Kim MM, Kotecha R, Kraemer L, Li J, Nagpal S, Rusthoven CG, Suh JH, Tome WA, Wang TJC, Zimmer AS, Ziu M, Brown PD (2022) Radiation therapy for brain metastases: an ASTRO clinical practice guideline. Pract Radiat Oncol 12:265–282. https://doi.org/10.1016/j.prro.2022.02.003

Article  PubMed  Google Scholar 

Vogelbaum MA, Brown PD, Messersmith H, Brastianos PK, Burri S, Cahill D, Dunn IF, Gaspar LE, Gatson NTN, Gondi V, Jordan JT, Lassman AB, Maues J, Mohile N, Redjal N, Stevens G, Sulman E, van den Bent M, Wallace HJ, Weinberg JS, Zadeh G, Schiff D (2022) Treatment for brain metastases: ASCO-SNO-ASTRO guideline. J Clin Oncol 40:492–516. https://doi.org/10.1200/JCO.21.02314

Article  CAS  PubMed  Google Scholar 

Theriault BC, Singh C, Yu J, Knisely J, Shepard M, Wegner RE, Warnick RE, Peker S, Samanci Y, Trifiletti DM, Lee CC, Yang HC, Bernstein K, Kondziolka D, Tripathi M, Mathieu D, Mantziaris G, Pikis S, Sheehan J, Chiang VL (2023) Selected-lesion stereotactic radiosurgery (SL-SRS) as a novel strategy in the treatment of patients with multiple brain metastases. Cureus 15:e45457. https://doi.org/10.7759/cureus.45457

Article  PubMed  PubMed Central  Google Scholar 

Ene CI, Abi Faraj C, Beckham TH, Weinberg JS, Andersen CR, Haider AS, Rao G, Ferguson SD, Alvarez-Brenkenridge CA, Kim BYS, Heimberger AB, McCutcheon IE, Prabhu SS, Wang CM, Ghia AJ, McGovern SL, Chung C, McAleer MF, Tom MC, Perni S, Swanson TA, Yeboa DN, Briere TM, Huse JT, Fuller GN, Lang FF, Li J, Suki D, Sawaya RE (2024) Response of treatment-naive brain metastases to stereotactic radiosurgery. Nat Commun 15:3728. https://doi.org/10.1038/s41467-024-47998-8

Article  CAS  PubMed  PubMed Central  Google Scholar 

Sneed PK, Mendez J, Vemer-van den Hoek JG, Seymour ZA, Ma L, Molinaro AM, Fogh SE, Nakamura JL, McDermott MW (2015) Adverse radiation effect after stereotactic radiosurgery for brain metastases: incidence, time course, and risk factors. J Neurosurg 123:373–386. https://doi.org/10.3171/2014.10.JNS141610

Article  PubMed  Google Scholar 

Moraes FY, Winter J, Atenafu EG, Dasgupta A, Raziee H, Coolens C, Millar BA, Laperriere N, Patel M, Bernstein M, Kongkham P, Zadeh G, Conrad T, Chung C, Berlin A, Shultz DB (2019) Outcomes following stereotactic radiosurgery for small to medium-sized brain metastases are exceptionally dependent upon tumor size and prescribed dose. Neuro Oncol 21:242–251. https://doi.org/10.1093/neuonc/noy159

Article  CAS  PubMed  Google Scholar 

Minniti G, Clarke E, Lanzetta G, Osti MF, Trasimeni G, Bozzao A, Romano A, Enrici RM (2011) Stereotactic radiosurgery for brain metastases: analysis of outcome and risk of brain radionecrosis. Radiat Oncol 6:48. https://doi.org/10.1186/1748-717X-6-48

Article  PubMed  PubMed Central  Google Scholar 

Soliman H, Ruschin M, Angelov L, Brown PD, Chiang VLS, Kirkpatrick JP, Lo SS, Mahajan A, Oh KS, Sheehan JP, Soltys SG, Sahgal A (2018) Consensus contouring guidelines for postoperative completely resected cavity stereotactic radiosurgery for brain metastases. Int J Radiat Oncol Biol Phys 100:436–442. https://doi.org/10.1016/j.ijrobp.2017.09.047

Article  PubMed  Google Scholar 

Choi CY, Chang SD, Gibbs IC, Adler JR, Harsh GR 4th, Lieberson RE, Soltys SG (2012) Stereotactic radiosurgery of the postoperative resection cavity for brain metastases: prospective evaluation of target margin on tumor control. Int J Radiat Oncol Biol Phys 84:336–342. https://doi.org/10.1016/j.ijrobp.2011.12.009

Article  PubMed  Google Scholar 

Kirkpatrick JP, Wang Z, Sampson JH, McSherry F, Herndon JE 2nd, Allen KJ, Duffy E, Hoang JK, Chang Z, Yoo DS, Kelsey CR, Yin FF (2015) Defining the optimal planning target volume in image-guided stereotactic radiosurgery of brain metastases: results of a randomized trial. Int J Radiat Oncol Biol Phys 91:100–108. https://doi.org/10.1016/j.ijrobp.2014.09.004

Lin NU, Lee EQ, Aoyama H, Barani IJ, Barboriak DP, Baumert BG, Bendszus M, Brown PD, Camidge DR, Chang SM, Dancey J, de Vries EG, Gaspar LE, Harris GJ, Hodi FS, Kalkanis SN, Linskey ME, Macdonald DR, Margolin K, Mehta MP, Schiff D, Soffietti R, Suh JH, van den Bent MJ, Vogelbaum MA, Wen PY (2015) Response assessment criteria for brain metastases: proposal from the RANO group. Lancet Oncol 16: e270–278.

Horky LL, Hsiao EM, Weiss SE, Drappatz J, Gerbaudo VH (2011) Dual phase FDG-PET imaging of brain metastases provides superior assessment of recurrence versus post-treatment necrosis. J Neurooncol 103:137–146. https://doi.org/10.1007/s11060-010-0365-8

Article  PubMed  Google Scholar 

Brigell RH, Cagney DN, Martin AM, Besse LA, Catalano PJ, Lee EQ, Wen PY, Brown PD, Phillips JG, Pashtan IM, Tanguturi SK, Haas-Kogan DA, Alexander BM, Aizer AA (2019) Local control after brain-directed radiation in patients with cystic versus solid brain metastases. J Neurooncol 142:355–363. https://doi.org/10.1007/s11060-019-03106-1

Article  PubMed  Google Scholar 

D’Andrea G, Palombi L, Minniti G, Pesce A, Marchetti P (2017) Brain metastases: surgical treatment and overall survival. World Neurosurg 97:169–177. https://doi.org/10.1016/j.wneu.2016.09.054

Article  PubMed  Google Scholar 

Popat S, Ahn MJ, Ekman S, Leighl NB, Ramalingam SS, Reungwetwattana T, Siva S, Tsuboi M, Wu YL, Yang JC (2023) Osimertinib for EGFR-mutant non-small-cell lung cancer central nervous system metastases: current evidence and future perspectives on therapeutic strategies. Target Oncol 18:9–24. https://doi.org/10.1007/s11523-022-00941-7

Article  PubMed  Google Scholar 

Tawbi HA, Forsyth PA, Algazi A, Hamid O, Hodi FS, Moschos SJ, Khushalani NI, Lewis K, Lao CD, Postow MA, Atkins MB, Ernstoff MS, Reardon DA, Puzanov I, Kudchadkar RR, Thomas RP, Tarhini A, Pavlick AC, Jiang J, Avila A, Demelo S, Margolin K (2018) Combined nivolumab and ipilimumab in melanoma metastatic to the brain. N Engl J Med 379:722–730. https://doi.org/10.1056/NEJMoa1805453

Article  CAS  PubMed  PubMed Central  Google Scholar 

Davies MA, Saiag P, Robert C, Grob JJ, Flaherty KT, Arance A, Chiarion-Sileni V, Thomas L, Lesimple T, Mortier L, Moschos SJ, Hogg D, Marquez-Rodas I, Del Vecchio M, Lebbe C, Meyer N, Zhang Y, Huang Y, Mookerjee B, Long GV (2017) Dabrafenib plus Trametinib in patients with BRAF(V600)-mutant melanoma brain metastases (COMBI-MB): a multicentre, multicohort, open-label, phase 2 trial. Lancet Oncol 18:863–873. https://doi.org/10.1016/S1470-2045(17)30429-1

Article  CAS  PubMed  PubMed Central  Google Scholar 

Lin NU, Murthy RK, Abramson V, Anders C, Bachelot T, Bedard PL, Borges V, Cameron D, Carey LA, Chien AJ, Curigliano G, DiGiovanna MP, Gelmon K, Hortobagyi G, Hurvitz SA, Krop I, Loi S, Loibl S, Mueller V, Oliveira M, Paplomata E, Pegram M, Slamon D, Zelnak A, Ramos J, Feng W, Winer E (2023) Tucatinib vs placebo, both in combination with trastuzumab and capecitabine, for previously treated ERBB2 (HER2)-positive metastatic breast cancer in patients with brain metastases: updated exploratory analysis of the HER2CLIMB randomized clinical trial. JAMA Oncol 9:197–205. https://doi.org/10.1001/jamaoncol.2022.5610

Article  PubMed  Google Scholar 

Grishchuk D, Dimitriadis A, Sahgal A, De Salles A, Fariselli L, Kotecha R, Levivier M, Ma L, Pollock BE, Regis J, Sheehan J, Suh J, Yomo S, Paddick I (2023) ISRS technical guidelines for stereotactic radiosurgery: treatment of small brain metastases (≤1 cm in diameter). Pract Radiat Oncol 13:183–194. https://doi.org/10.1016/j.prro.2022.10.013

Article  PubMed  Google Scholar 

Munoz L, Kron T, Petasecca M, Bucci J, Jackson M, Metcalfe P, Rosenfeld AB, Biasi G (2021) Consistency of small-field dosimetry, on and off axis, in beam-matched linacs used for stereotactic radiosurgery. J Appl Clin Med Phys 22:185–193. https://doi.org/10.1002/acm2.13160

Article  PubMed  PubMed Central  Google Scholar 

Kim PH, Suh CH, Kim HS, Kim KW, Kim DY, Aizer AA, Rahman R, Guenette JP, Huang RY (2021) Immune checkpoint inhibitor therapy may increase the incidence of treatment-related necrosis after stereotactic radiosurgery for brain metastases: a systematic review and meta-analysis. Eur Radiol 31:4114–4129. https://doi.org/10.1007/s00330-020-07514-0

Article  CAS  PubMed  Google Scholar